GetTopicDetailResponse(id=c869528548e, topicName=恩扎魯胺, introduction=恩扎魯胺, content=null, image=null, comments=1, allHits=1731, url=https://h5.medsci.cn/topic?id=52854, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=94860, tagList=[TagDto(tagId=94860, tagName=恩扎魯胺)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1201406, encodeId=84a912014061d, content=<a href='/topic/show?id=c869528548e' target=_blank style='color:#2F92EE;'>#恩扎魯胺#</a><a href='/topic/show?id=eb8b9e810aa' target=_blank style='color:#2F92EE;'>#阿帕魯胺#</a>與<a href='/topic/show?id=a45b1044e3f1' target=_blank style='color:#2F92EE;'>#達羅他胺#</a>未來好好PK一下了。, objectTitle=Eur Urol：異時性轉(zhuǎn)移激素敏感性前列腺癌男性中恩雜魯胺和雄激素阻斷療法治療的總生存率研究 , objectType=article, longId=212266, objectId=dc142122664a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202163/1622731754953_1935437.jpg, objectUrl=/article/show_article.do?id=dc142122664a, replyNumber=0, likeNumber=155, createdTime=2022-03-10, rootId=0, userName=醫(yī)者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc142122664a, moduleTitle=Eur Urol：異時性轉(zhuǎn)移激素敏感性前列腺癌男性中恩雜魯胺和雄激素阻斷療法治療的總生存率研究 , moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=dc142122664a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
